Vault-13

SILEXION THERAPEUTICS CORP SLXN

ORD SHS NEW · Common Stock · CUSIP G1281K130

0 institutional holders -7 vs Q1 2026
—reported value*
0 new 0 added 0 reduced 7 sold out net sold ≈ $46.7k (-36.5k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

0258Q2 25: 2Q3 25: 4Q4 25: 6Q1 26: 7Q2 26: 00Q2 25Q3 25Q4 25Q1 26Q2 26
Numbers
QuarterHolders
Q2 20252
Q3 20254
Q4 20256
Q1 20267
Q2 20260

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q3 25: 3 bought or addedQ3 25: 2 cut or sold outQ3 25Q4 25: 3 bought or addedQ4 25: 0 cut or sold outQ4 25Q1 26: 2 bought or addedQ1 26: 2 cut or sold outQ1 26Q2 26: 0 bought or addedQ2 26: 7 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q3 202532
Q4 202530
Q1 202622
Q2 202607

Biggest buyers

None

Biggest sellers

CITADEL ADVISORS LLC Sold out -20,926-20.9k
TWO SIGMA SECURITIES, LLC Sold out -11,657-11.7k
MONTAG A & ASSOCIATES INC Sold out -3,000-3.0k
UBS Group AG Sold out -517-517
Pflug Koory, LLC Sold out -333-333
JONES FINANCIAL COMPANIES LLLP Sold out -26-26
SBI Securities Co., Ltd. Sold out -20-20

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Moringa Sponsor, LP 13D · may seek influence -7.3 pts · filed 2026-09-28
Stated purposeThe information contained in Item 3 is incorporated by reference in its entirety into this Item 4. On June 22, 2026, Moringa Sponsor, LP filed a claim against Silexion Therapeutics Corp and two of its senior officers (the "Claim"), alleging deliberate and systematic breaches of the Amended and Restated Promissory Note, dated August 15, 2024 (the "Note"). In the Claim, Moringa Sponsor, LP alleges, among other things, that Silexion breached the conditions governing conversion of indebtedness under the Note, including by failing to use the correct share price for conversions, failing to provide the required prior notice, effecting conversions below the minimum amount, and failing to deliver the shares within the required timeframe. Moringa Sponsor, LP seeks a declaration that the purported co… Full filing
17.7% -7.3 pts 2.0m 2026-09-28

Fell to 5% or below in the last year: INTRACOASTAL CAPITAL, LLC (5.0%, 2026-08-18)

Insider purchases and sales since 1 Apr 2026

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q4 24: 0 buyingQ4 24: 0 sellingQ1 25: 0 buyingQ1 25: 0 sellingQ1 25Q2 25: 0 buyingQ2 25: 0 sellingQ3 25: 0 buyingQ3 25: 0 sellingQ3 25Q4 25: 0 buyingQ4 25: 0 sellingQ1 26: 0 buyingQ1 26: 1 sellingQ1 26Q2 26: 0 buyingQ2 26: 0 sellingQ3 26: 0 buyingQ3 26: 0 sellingQ3 26
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20240—0——
Q1 20250—0——
Q2 20250—0——
Q3 20250—0——
Q4 20250—0——
Q1 20260—1——
Q2 20260—0——
Q3 20260—0——

None reported since 1 Apr 2026.

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change